Joseph Pantginis

Stock Analyst at HC Wainwright & Co.

(0)
# 4710
Out of 5,378 analysts
998
Total ratings
Success rate
Average return
86 Stocks
Name Action PT Current % Upside Ratings Updated
LCTX Lineage Cell Therape...
Reiterates: Buy
9 9
0.97 827.84% 12 Jun 23, 2025
MBRX Moleculin Biotech
Reiterates: Buy
4 4
n/a n/a 2 Jun 18, 2025
CDTX Cidara Therapeutics
Assumes: Buy
41
44.83 -8.54% 1 Jun 18, 2025
ESPR Esperion Therapeutic...
Reiterates: Buy
16 16
1.04 1438.46% 29 Jun 17, 2025
GALT Galectin Therapeutic...
Assumes: Buy
6
2.48 141.94% 1 Jun 17, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
26 26
3.98 553.27% 14 Jun 17, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
50 50
20.32 146.06% 35 Jun 16, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
77 77
7.71 898.7% 22 Jun 13, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
16 16
5.59 186.23% 20 Jun 13, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
10 10
1.29 675.19% 3 Jun 11, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
13 13
1.55 738.71% 31 Jun 11, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Assumes: Buy
14
2.19 539.27% 1 Jun 5, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
35 35
5 600% 9 Jun 4, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 4 Jun 2, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
104 104
26.02 299.69% 24 May 28, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
7 9
1.9 373.68% 15 May 19, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Assumes: Buy
17
2.19 676.26% 1 May 19, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
21 15
0.47 3091.49% 15 May 16, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
32 32
11.48 178.75% 6 May 16, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
16 16
1.56 925.64% 12 May 15, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
250 250
5.45 4487.16% 3 May 13, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
4 4
1.52 163.16% 30 May 12, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
32 20
1.85 981.08% 28 May 9, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Assumes: Buy
9
0.95 847.37% 1 May 8, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
240 240
137.97 73.95% 30 May 6, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
40 18
1.71 952.63% 30 May 6, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Strong Buy
11 15
7.95 88.68% 9 Apr 30, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
40 40
5.86 582.59% 26 Apr 28, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
6 5
0.93 383.87% 22 Apr 25, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
5 5
0.55 809.09% 16 Apr 25, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
102 102
24.88 309.97% 32 Apr 24, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
24 24
2.54 844.88% 18 Apr 21, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
120 120
32.59 268.21% 48 Apr 21, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
16 16
6.87 132.9% 19 Apr 10, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Neutral
n/a
n/a n/a 9 Apr 9, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
31 31
4.17 643.41% 31 Apr 8, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
12
0.63 1804.76% 1 Apr 3, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
2 6
n/a n/a 17 Mar 28, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
4 4
0.73 447.95% 21 Mar 28, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Neutral
n/a
n/a n/a 18 Mar 27, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
37 37
10.69 246.12% 17 Mar 21, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
11 11
1.6 587.5% 7 Mar 19, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
5
n/a n/a 18 Mar 11, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
57 57
18.81 203.03% 26 Mar 5, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
17 7
n/a n/a 29 Feb 13, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
8 21
6.09 244.83% 1 Feb 4, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
20 20
1.64 1119.51% 14 Jan 15, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
25 25
2.04 1125.49% 16 Dec 18, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
15 15
2.44 514.75% 16 Dec 11, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
n/a
n/a n/a 20 Dec 11, 2024